CRBP·21833P301·US·equity·Healthcare - Biotechnology-13D/G
CRBP (CORBUS PHARMACEUTICALS HLDGS) is held by 54 institutional investors as of Q1 2026. Largest holders: Aberdeen Group plc ($12.4M), CITADEL ADVISORS LLC ($6.8M), RENAISSANCE TECHNOLOGIES LLC ($3.3M). Net institutional sentiment: Mixed.
See how CRBP's score breaks down across 4 SEC sources
Showing 1-20 of 61
Data sourced from four SEC data sources: 13F, Form 4, 13D/13G, and STOCK Act. Not financial advice. Full disclaimer